Quantcast

Latest Alcohols Stories

2014-06-05 12:24:18

HOUSTON, June 5, 2014 /PRNewswire/ -- G2X Energy, Inc. ("G2X") announced today that the State of Louisiana and the Federal EPA have granted its wholly-owned subsidiary, Big Lake Fuels LLC, the required air permits to construct and operate a natural gas-to-gasoline facility in Lake Charles, Louisiana. The permits, issued by the Louisiana Department of Environmental Quality ("LDEQ") on May 23rd, are the first permits to allow for the construction and operation of a commercial scale...

2014-06-05 08:27:57

JAMA Psychiatry Study confirms Waismann Method research that heroin addiction is prevalent in the inner-city as well as in white suburbs and rural areas. BEVERLY HILLS, Calif., June 5, 2014 /PRNewswire/ -- A research paper published in the May 28, 2014 issue of JAMA Psychiatry a paper entitled "The Changing Face of Heroin Use in the United States A Retrospective Analysis of the Past 50 Years" concluded that heroin abuse has left low-income urban areas and has become prevalent in...

2014-06-04 23:04:48

ChinaMarketResearchReports.com adds Latest Report on “China Vitamin Industry Report, 2014-2017” to its store. Inquire before buying on this report at http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114824. Dallas, TX (PRWEB) June 04, 2014 China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total output and vitamin...

2014-06-04 12:30:20

PORTLAND, Ore., June 4, 2014 /PRNewswire/ -- Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler. "Paragon is committed to working proactively with the FDA in an effort to prevent disrupting...

2014-06-03 08:32:29

Multi-Tranche Financing Provides Sufficient Funding to Take KP201 Through and Beyond Potential FDA Approval and Enables KemPharm to Advance its Full Pipeline of Abuse-Deterrent Prodrugs CORALVILLE, Iowa, June 3, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has entered into a $60 million financing agreement with an investment fund managed by...

2014-05-30 23:16:07

To help retailers get prepared, Essential Wholesale & Labs has developed a list of its top five recommended products for summer. Portland, Oregon (PRWEB) May 30, 2014 "With summer fast approaching, now is the time to make sure you have high demand summer products ready," says Laura Badcock, General Manager of Essential Wholesale & Labs. To help retailers get prepared, Essential has developed a list of its top five recommended products for summer. Clarifying Facial...

2014-05-30 08:22:17

MarketReportsStore.com adds "Amphoteric Surfactant Market by Application (Personal Care, Home Care and Industrial & Institutional, Oil Field Chemical, Agriculture Adjuvants), Type (Betaine, Amine Oxide, Amphoacetate, Amphopropionate, Sultaine) - Global Trends & Forecast to 2019" & "Choline Chloride Market by End-User (Poultry feed, Swine feed, Ruminant feed, Aqua feed & others, Human nutrition and Oil & Gas, and Misc. applications), and Geography - Regional Trends & Forecast to 2019" its...

2014-05-27 12:10:00

Brigham and Women's Hospital Both treatments shown effective for hot flashes and night sweats A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found effective in reducing the number of hot flashes and night sweats reported by menopausal women. The study is the first clinical trial to simultaneously evaluate estrogen therapy (ET), known as the...

2014-05-23 16:24:17

OTTAWA, May 23, 2014 /CNW/ - The issue: Pharmascience Inc., in consultation with Health Canada, is recalling one lot of PMS-Losartan-HCTZ due to a labelling error on the blister pack (see photo below). The printed boxes of the product show the proper dosage "Losartan-HCTZ100/25mg," while some blisters or inner packages incorrectly say "Losartan-HCTZ 100/12.5mg." The product is packaged with 100/25mg tablets. Taking more of the drug than prescribed could have serious health...

2014-05-21 23:10:53

Healthesystems clinicians assembled a valuable resource for workers’ compensation payers to share with prescribers who are treating patients for chronic pain with opioid therapy. Tampa, Fla. (PRWEB) May 21, 2014 Implementation of an aggressive opioid management strategy that includes opioid dose tapering can minimize risks to injured workers and workers’ compensation claims organizations. Long-term opioid therapy carries significant risks and can lead to complex, escalating and...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related